Scientists in Scotland are to test a new vaccine to treat a deadly form of brain cancer.
Cancer Research UK and Cancer Research Technology - the charity's development and commercialisation arm - have launched the first clinical trial of a promising cancer vaccine to treat glioblastoma.
The treatment, IMA950, will direct and boost the body's immune system to enable it to fight cancer.
The vaccine will be used together with the standard treatments of surgery, radiotherapy and chemotherapy.
The trial is taking place at the Beatson West of Scotland Cancer Centre in Glasgow and up to four other hospitals yet to be confirmed across the UK.
Professor Roy Rampling, from the University of Glasgow who will lead the study, said: "Glioblastoma can be challenging to treat because there are limited options for therapy; there's a real need for new treatments for this disease."